As the COVID-19 vaccination drive in India set to roll out soon, Serum Institute of India (SII) officials confirmed that it has received a purchase order for its vaccine Covishield from the central government. The Centre has placed purchase order with Serum Institute for 11 million doses of Covishield.
“We have received the (purchase) order from the Government of India on Monday afternoon,” a senior SII official told PTI. The government has announced that the process of administering the vaccine will start on on January 16.
Each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10 it would cost Rs 210. The Rs 200 price has been decided for the first 100 million doses so far.
According to the union health ministry, a person has to take two doses of the coronavirus vaccine 28 days apart to complete the immunisation schedule.
Drugs Controller General of India (DCGI), on January 5, announced approval of two vaccines — Oxford-AstraZeneca’s Covishield manufactured by SII and Bharat Biotech’s Covaxin — against coronavirus infection for restricted emergency use.
As per the union health ministry, the national COVID-19 recovery rate stands at 96.43 per cent and the case fatality rate was recorded at 1.44 per cent.